These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24336051)

  • 1. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice.
    Acuña AI; Esparza M; Kramm C; Beltrán FA; Parra AV; Cepeda C; Toro CA; Vidal RL; Hetz C; Concha II; Brauchi S; Levine MS; Castro MA
    Nat Commun; 2013; 4():2917. PubMed ID: 24336051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired intracellular trafficking of sodium-dependent vitamin C transporter 2 contributes to the redox imbalance in Huntington's disease.
    Covarrubias-Pinto A; Parra AV; Mayorga-Weber G; Papic E; Vicencio I; Ehrenfeld P; Rivera FJ; Castro MA
    J Neurosci Res; 2021 Jan; 99(1):223-235. PubMed ID: 32754987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease.
    Covarrubias-Pinto A; Moll P; Solís-Maldonado M; Acuña AI; Riveros A; Miró MP; Papic E; Beltrán FA; Cepeda C; Concha II; Brauchi S; Castro MA
    Free Radic Biol Med; 2015 Dec; 89():1085-96. PubMed ID: 26456058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice.
    McClory H; Williams D; Sapp E; Gatune LW; Wang P; DiFiglia M; Li X
    Acta Neuropathol Commun; 2014 Dec; 2():179. PubMed ID: 25526803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.
    Li X; Valencia A; Sapp E; Masso N; Alexander J; Reeves P; Kegel KB; Aronin N; Difiglia M
    J Neurosci; 2010 Mar; 30(13):4552-61. PubMed ID: 20357106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression.
    Solís-Maldonado M; Miró MP; Acuña AI; Covarrubias-Pinto A; Loaiza A; Mayorga G; Beltrán FA; Cepeda C; Levine MS; Concha II; Bátiz LF; Carrasco MA; Castro MA
    CNS Neurosci Ther; 2018 Apr; 24(4):343-352. PubMed ID: 29582588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
    Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
    Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
    Liévens JC; Woodman B; Mahal A; Spasic-Boscovic O; Samuel D; Kerkerian-Le Goff L; Bates GP
    Neurobiol Dis; 2001 Oct; 8(5):807-21. PubMed ID: 11592850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
    Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
    Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
    Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.
    Murmu RP; Li W; Holtmaat A; Li JY
    J Neurosci; 2013 Aug; 33(32):12997-3009. PubMed ID: 23926255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.
    Wójtowicz AM; Dvorzhak A; Semtner M; Grantyn R
    Front Neural Circuits; 2013; 7():188. PubMed ID: 24324407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
    Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
    Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions.
    Boussicault L; Hérard AS; Calingasan N; Petit F; Malgorn C; Merienne N; Jan C; Gaillard MC; Lerchundi R; Barros LF; Escartin C; Delzescaux T; Mariani J; Hantraye P; Beal MF; Brouillet E; Véga C; Bonvento G
    J Cereb Blood Flow Metab; 2014 Sep; 34(9):1500-10. PubMed ID: 24938402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
    Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
    Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.
    Rebec GV
    Antioxid Redox Signal; 2013 Dec; 19(17):2115-28. PubMed ID: 23642110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.